AMAIA
ARRUABARRENA ARISTORENA
INVESTIGADOR/A DOCTOR/A
Centro de Investigación Biomédica en Red de Cáncer
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Centro de Investigación Biomédica en Red de Cáncer (5)
2022
-
PI3K-regulated Glycine N-methyltransferase is required for the development of prostate cancer
Oncogenesis, Vol. 11, Núm. 1
2020
-
Targeting PML in triple negative breast cancer elicits growth suppression and senescence
Cell Death and Differentiation, Vol. 27, Núm. 4, pp. 1186-1199
2018
-
Low-dose statin treatment increases prostate cancer aggressiveness
Oncotarget, Vol. 9, Núm. 2, pp. 1494-1504
-
Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism
Science Advances, Vol. 4, Núm. 1
-
PPARd elicits ligand-independent repression of trefoil factor family to limit prostate cancer growth
Cancer Research, Vol. 78, Núm. 2, pp. 399-409